Johanna Hynninen
 Adjunct professor, MD, Gynecologic oncologist

  

  

  

7 of 10

  

  

  

---

• RNA-seq analysis of high-grade serous ovarian cancer patients before and after chemotherapy reveals chemoresistance-associated genes and pathways  (2020)  
  • Clinical Cancer Research
   Jamalzadeh S, Zhang KY, Hakkinen A, Huhtinen K, Hynninen J, Andersson N, Mansuri N, Carpen O, Erdogan E, Dai J, Vaharautio A, Hietanen S, Oikkonen J, Lehtonen R, Hautaniemi S

  
  

• Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer  (2020)  
  • Clinical Cancer Research
   Erkan EP, Dai J, Zhang KY, Kaipio K, Lamminen T, Mansuri N, Suominen L, Alkodsi A, Huhtinen K, Hietanen S, Hynninen J, Grenman S, Carpen O, Hautaniemi S, Vaharautio A

  
  

• The feasibility of [F-18]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study  (2020)  
  • EJNMMI Research
   Maren Laasik, Johanna Hynninen, Sarita Forsback, Tommi Noponen, Marko Seppänen, Sakari Hietanen

  
  

• Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study  (2019)  
  • Cancer Imaging
   Laasik M, Kemppainen J, Auranen A, Hietanen S, Grénman S, Seppänen M, Hynninen J

  
  

• CtDNA profiling to predict prognosis and optimize treatment in high-grade serous ovarian cancer  (2019)  
  • Clinical Cancer Research
   Oikkonen J, Zhang KY, Salminen L, Huhtinen K, Schulman I, Andersson N, Carpen O, Hietanen S, Grenman S, Lehtonen R, Hynninen J, Farkkila A, Hautaniemi S

  
  

• Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources  (2019)  
  • The Journal of Applied Laboratory Medicine
   Gidwani K, Nadeem N, Huhtinen K, Kekki H, Heinosalo T, Hynninen J, Perheentupa A, Poutanen M, Carpen O, Pettersson K, Lamminmäki U

  
  

• Open Source Infrastructure for Health Care Data Integration and Machine Learning Analyses  (2019)  
  • JCO Clinical Cancer Informatics
   Isoviita VM, Salminen L, Azar J, Lehtonen R, Roering P, Carpén O, Hietanen S, Grénman S, Hynninen J, Färkkilä A, Hautaniemi S

  
  

• PET/CT for Evaluation of Ovarian Cancer  (2019)  
  • Seminars in Nuclear Medicine
   Jukka Kemppainen, Johanna Hynninen, Johanna Virtanen, Marko Seppänen

  
  

• Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer  (2019)  
  • JCO Precision Oncology
   Oikkonen J, Zhang KY, Salminen L, Schulman I, Lavikka K, Andersson N, Ojanperä E, Hietanen S, Grenman S, Lehtonen R, Huhtinen K, Carpen O, Hynninen J, Färkkilä A, Hautaniemi S

  
  

• Virtual clinical trials identify effective combination therapies in ovarian cancer  (2019)  
  • Scientific Reports
   Kozlowska E, Vallius T, Hynninen J, Hietanen S, Farkkila A, Hautaniemi S